Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.42 USD | +2.09% |
|
-6.37% | -21.51% |
27/06 | BNP Paribas Exane Adjusts Price Target on Aptiv to $100 From $105, Keeps Outperform Rating | MT |
26/06 | Equities Mostly Rise as Markets Weigh New-Home Sales Data | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.51% | 1.92TCr | |
+17.44% | 4.52TCr | |
+14.57% | 1.87TCr | |
+28.11% | 1.67TCr | |
+6.12% | 1.63TCr | |
+86.57% | 1.55TCr | |
+39.38% | 1.21TCr | |
+53.36% | 1.2TCr | |
-26.76% | 1.2TCr | |
-31.23% | 1.13TCr |
- Stock Market
- Equities
- APTV Stock
- News Aptiv PLC
- BNP Paribas Exane Adjusts Price Target on Aptiv to $100 From $105, Keeps Outperform Rating